摘要
目的:观察子宫动脉栓塞联合宫腔镜清宫术治疗剖宫产瘢痕部位妊娠(CSP)患者的效果。方法:选取65例CSP患者作为研究对象,按照随机数字表法分为对照组(32例)和研究组(33例),对照组采用甲氨蝶呤联合宫腔镜清宫术治疗,研究组采用双侧子宫动脉栓塞联合宫腔镜清宫术治疗。比较两组患者的手术时间、术中出血量、住院时间、血清人绒毛膜促性腺激素(β-hCG)水平恢复时间、治疗有效率、并发症发生率及不良反应发生率。结果:研究组的手术时间、术中出血量、住院时间和血β-hCG水平恢复时间均少于或短于对照组,差异有统计学意义(P<0.05);研究组的治疗有效率为96.97%,高于对照组的78.13%,差异有统计学意义(P<0.05);研究组的并发症发生率及不良反应发生率均明显低于对照组,差异有统计学意义(P<0.05)。结论:子宫动脉栓塞联合宫腔镜清宫术治疗CSP患者可提高治疗有效率和降低不良反应发生率,效果优于甲氨蝶呤联合宫腔镜清宫术治疗效果。
Objective: To explore effects of uterine artery embolization combined with hysteroscopic uterine curettage in treatment of patients with cesarean scar pregnancy(CSP). Methods: 65 patients with CSP were selected as the research objects, and were divided into control group(n=32) and study group(n=33) according to the random number table method. The control group was treated with Methotrexate combined with hysteroscopic uterine curettage, while the study group used bilateral uterine artery embolization combined with hysteroscopic uterine curettage. Then, the operation time, intraoperative blood loss, hospitalization time, blood β-hCG recovery time, treatment effective rate, incidence of complications and incidence of adverse reactions were compared between the two groups. Results: The operation time, intraoperative blood loss, hospitalization time and blood β-hCG recovery time of the study group were all less or shorter than those of the control group, and the differences were statistically significant(P<0.05). The treatment effective rate in the study group was 96.97%, which was significantly higher than 78.13% in the control group, and the difference was statistically significant(P<0.05). Further, the incidence of complications and incidence of adverse reactions in the study group were significantly lower than those in the control group, the differences were statistically significant(P<0.05). Conclusions: Uterine artery embolization combined with hysteroscopic uterine curettage in the treatment of the patients with CSP can improve the treatment effective rate and reduce the incidence of adverse reactions. Moreover, it is superior to Methotrexate combined with hysteroscopic uterine curettage.
作者
石秀岩
SHI Xiuyan(Jianchang County People’s Hospital,Huludao 125300 Liaoning,China)
出处
《中国民康医学》
2020年第5期14-16,共3页
Medical Journal of Chinese People’s Health
关键词
剖宫产瘢痕部位妊娠
清宫术
宫腔镜
Cesarean scar pregnancy
Uterine curettage
Hysteroscopy